广西医学
廣西醫學
엄서의학
GUANGXI MEDICAL JOURNAL
2014年
3期
326-328
,共3页
覃乃辉%周达利%秦立%黄慧嫔
覃迺輝%週達利%秦立%黃慧嬪
담내휘%주체리%진립%황혜빈
肺癌%纤维蛋白原%D-二聚体%抗凝血酶Ⅲ
肺癌%纖維蛋白原%D-二聚體%抗凝血酶Ⅲ
폐암%섬유단백원%D-이취체%항응혈매Ⅲ
Lung cancer%Fibrinogen%D-dimer%AntithrombinⅢ
目的:观察肺癌患者血浆纤维蛋白原( FIB )、D-二聚体及抗凝血酶Ⅲ( AT-Ⅲ)水平变化并探讨其临床意义。方法肺癌患者73例(观察组),健康志愿者60例(对照组),检测两组血浆FIB、D-二聚体及AT-Ⅲ水平。结果观察组血浆FIB、D-二聚体水平显著高于对照组,而AT-Ⅲ水平显著低于对照组( P均<0.05);Ⅲ、Ⅳ期患者血浆FIB、D-二聚体水平高于Ⅰ、Ⅱ期(P<0.05),而Ⅲ、Ⅳ期患者AT-Ⅲ水平低于Ⅰ、Ⅱ期(P<0.05)。结论检测FIB、D-二聚体以及AT-Ⅲ的水平可作为肺癌进展的辅助诊断指标。
目的:觀察肺癌患者血漿纖維蛋白原( FIB )、D-二聚體及抗凝血酶Ⅲ( AT-Ⅲ)水平變化併探討其臨床意義。方法肺癌患者73例(觀察組),健康誌願者60例(對照組),檢測兩組血漿FIB、D-二聚體及AT-Ⅲ水平。結果觀察組血漿FIB、D-二聚體水平顯著高于對照組,而AT-Ⅲ水平顯著低于對照組( P均<0.05);Ⅲ、Ⅳ期患者血漿FIB、D-二聚體水平高于Ⅰ、Ⅱ期(P<0.05),而Ⅲ、Ⅳ期患者AT-Ⅲ水平低于Ⅰ、Ⅱ期(P<0.05)。結論檢測FIB、D-二聚體以及AT-Ⅲ的水平可作為肺癌進展的輔助診斷指標。
목적:관찰폐암환자혈장섬유단백원( FIB )、D-이취체급항응혈매Ⅲ( AT-Ⅲ)수평변화병탐토기림상의의。방법폐암환자73례(관찰조),건강지원자60례(대조조),검측량조혈장FIB、D-이취체급AT-Ⅲ수평。결과관찰조혈장FIB、D-이취체수평현저고우대조조,이AT-Ⅲ수평현저저우대조조( P균<0.05);Ⅲ、Ⅳ기환자혈장FIB、D-이취체수평고우Ⅰ、Ⅱ기(P<0.05),이Ⅲ、Ⅳ기환자AT-Ⅲ수평저우Ⅰ、Ⅱ기(P<0.05)。결론검측FIB、D-이취체이급AT-Ⅲ적수평가작위폐암진전적보조진단지표。
Objective To observe the changes of plasma fibrinogen ( FIB ) , D-dimer and antithrombin Ⅲ( AT-Ⅲ) in patients with lung cancer ,and to explore their clinical significance .Methods Seventy-three cases of lung cancer(observation group) and 60 healthy volunteers(control group) were enrolled in the study,the plasma FIB,D-dimer and AT-Ⅲlevels were detected in two groups .Results The FIB,D-dimer levels of observation group were significantly higher than those of control group,while the AT-Ⅲlevel was significantly lower than that of control group (all P<0.05). The plasma FIB,D-dimer levels of patients in phases Ⅲ,Ⅳwere higher than those of patients in phasesⅠ,Ⅱ(P<0.05), while the AT-Ⅲlevel of patients in phases Ⅲ,Ⅳwas lower than that of patients in phasesⅠ,Ⅱ(P<0.05).Conclusion The detection of FIB ,D-dimer and AT-Ⅲlevels can be used as the auxiliary indexes for the diagnosis of lung cancer progression .